| Net Cash Provided by (Used in) Financing Activities |
$110,590,000 |
USD |
|
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Investing Activities |
$33,252,000 |
USD |
33% |
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
118,000,000 |
shares |
0% |
Q2 2024 |
Q2 2024 |
| Common Stock, Shares, Issued |
52,007,495 |
shares |
|
Q2 2024 |
Q2 2024 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$77,592,000 |
USD |
81% |
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$527,713,000 |
USD |
116% |
Q2 2024 |
Q2 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$127,018,000 |
USD |
20% |
Q1 2024 |
Q1 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$335,562,000 |
USD |
-106% |
Q2 2024 |
Q2 2024 |
| Operating Lease, Liability, Current |
$74,640,000 |
USD |
-5% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Shares Issued |
3 |
shares |
0% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Shares Authorized |
2,000,000 |
shares |
0% |
Q2 2024 |
Q2 2024 |
| Additional Paid in Capital |
$296,077,000 |
USD |
2.2% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Shares Outstanding |
3 |
shares |
0% |
Q2 2024 |
Q2 2024 |
| Depreciation, Depletion and Amortization |
$135,635,000 |
USD |
1.1% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |